| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Cue Biopharma, Inc.
13D
CUE · 22978P205
|
6.2% |
8/21/2026
Event 5/3/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.